SLC2A1 and breast cancer: Our data suggest that CELF1 is expressed and functional in different molecular subtypes of breast cancer; additionally, CELF1 drives the metabolic preference for aerobic glycolysis in breast carcinomas by modulating the expression of GLUT1.